St. Jude Researchers Identify Cancer Development and Treatment Resistance Mechanisms

AI-generated NewsSnap summary based on source reporting.
Published: 2026-10-29
Category: science
Source: St. Jude Children's Research Hospital
Original source

Scientists at St. Jude Children's Research Hospital have identified how an altered factor in messenger RNA (mRNA) decoding contributes to cancer development and treatment resistance. Published in Nature Cell Biology, their research shows the METTL13 enzyme stimulates proliferation-promoting proteins like KRAS. Reducing METTL13 activity could offer a new therapeutic strategy for KRAS-driven cancers.

Want more?

Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.

Open NewsSnap.ai